An independent research, systems and ventures platform combining clinical, quantitative, policy and engineering practice across global health, development and scientific technology.
Important decisions often move through separate teams: researchers define the evidence, analysts produce estimates, designers communicate them, and technologists build the system. Meaning and accountability can be lost at every handover.
Reyanda was founded by Geoffrey Manda as a platform where those disciplines can remain connected. Its work begins with causal and statistical clarity, preserves provenance and uncertainty, and ends in something an institution, researcher or user can inspect and act on.
The current portfolio includes an active doctoral programme, applied health-systems research, technical advisory, scientific design infrastructure and a growing group of public-interest ventures.
Health questions are grounded in people, care pathways and the consequences of getting a decision wrong.
Design, estimand, bias, uncertainty and limitations determine what can be claimed.
Policies, data flows, institutions and incentives are treated as interacting parts rather than isolated deliverables.
Tools are built when they can reduce repeated friction, preserve provenance or make difficult work more usable.
Reyanda runs as a social enterprise on a single operating model with two arms. They share one team, one method and one standard of evidence; what differs is who pays and who the output belongs to.
Software licensed to research groups, agencies and institutions, and advisory engagements delivered against a brief. This is where revenue comes from.
Medantir, our first product ›Doctoral and applied research, food and social policy analysis, and the open methods work behind our figures and evidence standards. Published rather than sold.
Current research ›Reyanda is a registered business in Malawi (BRN-KGS5RRJ). The two arms are an operating structure, not separate legal entities.
A small senior team. Each lead owns a practice area end to end, from the question through the analysis to the thing an institution can act on.
Clinician-researcher and quantitative modeller. Owns product direction for the ventures arm and technical delivery on client engagements, and leads the research programmes.
Owns health and development analysis on client engagements — scoping the question, running the analysis, and delivering something the client can act on and defend.
Owns monitoring, evaluation and learning engagements: designing the measurement framework a programme is held to, and turning what it produces into decisions.
Owns policy and financing engagements, from national commitments through to the instruments and budgets that decide whether they reach anyone.
Truth before theatre. Project maturity and uncertainty remain public.
Human adjudication. Automation can detect and organise; accountable experts still decide.
Public value. Technical ambition must connect to real research, health or development needs.
Institutional independence. Client, university and founder work are attributed separately, with no implied endorsement.
Advisory, research and venture conversations each begin with a different brief.